Short treatment with sofosbuvir and ledipasvir over only 6 weeks is sufficient to cure acute hepatitis C (HCV)
A pilot study presented today found that all patients with acute HCV who were treated with a direct-acting antiviral treatment over a ‘short-duration’ of six weeks had undetectable HCV after a 12 week follow-up. The investigator-initiated study, presented at The International Liver CongressTM in Barcelona, Spain, demonstrated that the combination of sofosbuvir and ledipasvir for only six weeks is sufficient to treat patients with acute HCV.
Those infected with HCV usually develop acute Hepatitis C, which spontaneously clears in 10 to 50% of infected persons. Early diagnosis of HCV infection is rare and the disease may go unnoticed until patients have already developed serious liver damage.1 Sofosbuvir and ledipasvir is one possible regimen for treatment of patients with chronic HCV. Sustained virologic response (SVR) is greater than 95% with a 12-week course of this treatment.2
“Given the high cost of sofosbuvir and ledipasvir, and the associated side effects that occur during treatment, we set out to assess whether shortened treatment duration could be an effective option for acute Hepatitis C patients,” said Katja Deterding from Hannover Medical School, Germany and study author. “Our research demonstrates that not only is the combination of sofosbuvir and ledipasvir safe, well tolerated and effective in acute HCV genotype 1 patients who have severe liver disease with very high liver enzymes, but a shorter treatment duration does not appear to hinder efficacy,” confirmed Professor Heiner Wedemeyer, the senior author of this study.
The German pilot study, performed by the German HepNet Study-House included 20 patients. Risk factors of HCV infection among the study members included; sexual transmission (n=11), medical procedures/needle stick injury (n=5), drug use (n=1), and nail treatment complications (n=1). The causes were unspecified for the remaining two patients.
All 20 patients completed six weeks of sofosbuvir and ledipasvir without ribavirin. At the 12 week follow up, all 20 patients had undetectable HCV and achieved SVR (100%). Fatigue was the most frequent side effect reported by study members (30%).
“These exciting findings open up short and cost-effective treatment options that could prevent the spread of HCV in high risk populations,” said Professor Frank Tacke, EASL Governing Board member. “We look forward to seeing this pilot study extended so the findings can be validated and then hopefully used as a tool to change clinical practice for the better.”
Learn more:Â Scientists find a way to cure hepatitis C with 6 weeks of treatment
The Latest on: Hepatitis C
[google_news title=”” keyword=”Hepatitis C” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hepatitis C
- ‘I’ve suffered decades of pain with hepatitis C from contaminated blood’on May 11, 2024 at 10:00 pm
Ingrid Western has suffered received years of physical and mental trauma after being infected with contaminated blood products ...
- CNIC issuance & renewal: NADRA urged to make hepatitis screening mandatoryon May 11, 2024 at 3:09 pm
KARACHI: With an estimated 15 million people affected by Hepatitis B and C in Pakistan, leading gastroenterologists have urged the National Database and Registration Authority (NADRA) to make ...
- Hepatitis C testing offered in 2 free clinics at Central Libraryon May 11, 2024 at 11:04 am
Connect to Cure is offering free Hepatitis C testing at two locations this May at ce3ntral Library in downtown Indianapolis ...
- Let’s make hepatitis C history in Canadaon May 10, 2024 at 3:00 am
Registered nurse Tina Woodruff from Niagara Health's hepatitis C care clinic tests a woman for the virus during a 2019 event to raise awareness and encourage more people to get tested. Canada has made ...
- Opinion: Let’s make hepatitis-C history in Canadaon May 9, 2024 at 4:03 pm
Thankfully for some survey participants, there were no cash prizes for correct answers. Because we got a lot of untrue statements. No, you don’t get hepatitis-C from eating or drinking contaminated ...
- Infected blood scandal: Hundreds ‘unaware they have hepatitis C’on May 9, 2024 at 5:44 am
Evidence suggests patients at risk after transfusions were not traced and warned by the NHS because it was too costly ...
- Infected blood: Hundreds of victims living with undetected hepatitis Con May 9, 2024 at 4:01 am
About 1,750 people in the UK are living with an undiagnosed hepatitis C infection after being given a transfusion with contaminated blood, according to BBC analysis. Official documents, seen by BBC ...
- Nearly 2,000 people unaware they have hepatitis C from infected bloodon May 9, 2024 at 2:29 am
Around 1,750 people are living with an undiagnosed hepatitis C infection after being given contaminated blood, a BBC analysis has found.
- DHEC Encourages Hepatitis C Testing During Hepatitis Awareness Monthon May 8, 2024 at 8:06 am
May is National Hepatitis Awareness Month, and the South Carolina Department of Health and Environmental Control is encouraging South Carolinians to know their status and get tested.
- DHEC advises South Carolinians to get tested for viral hepatitison May 6, 2024 at 6:48 pm
Hepatitis refers to inflammation of the liver. Viral hepatitis is an infectious disease caused by a virus. Hepatitis is what some medical professionals call ‘a hidden illness.’ “A lot of people don’t ...
via Bing News